First-of-its-kind STARD(3) Inhibitor: In Silico Identification and Biological Evaluation as Anticancer Agent

[Image: see text] STARD3 is a cellular protein that represents an attractive target for cancer therapy, being overexpressed in breast cancer and implied in the development of colorectal, gastric, and prostate cancers. Unfortunately, no STARD3 inhibitor has been identified yet. In this work, an in si...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:ACS Med Chem Lett
Main Authors: Lapillo, Margherita, Salis, Barbara, Palazzolo, Stefano, Poli, Giulio, Granchi, Carlotta, Minutolo, Filippo, Rotondo, Rossella, Caligiuri, Isabella, Canzonieri, Vincenzo, Tuccinardi, Tiziano, Rizzolio, Flavio
Formato: Artigo
Idioma:Inglês
Publicado em: American Chemical Society 2019
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6466518/
https://ncbi.nlm.nih.gov/pubmed/30996782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acsmedchemlett.8b00509
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados